Posted by: Indonesian Children | November 11, 2010

References and Bibliography of Asthma

References and Bibliography of Asthma

  • National Heart, Lung, and Blood Institute. Global Initiative for Asthma. 1995. National Institute for Health Publication; 95-3659.
  • Global strategy for asthma management and prevention. Global initiative for asthma (GINA) 2006. Available at http://ginasthma.org.
  • National Health Interview Survey, National Center for Health Statistics. CDC. Available at http://www.cdc.gov/nchs/products/pubs/pubd/hestats/ashtma03-05/asthma03-05.htm.
  • National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. NIH Publication No. 97-4051. NIH Publication. 1997;[Full Text].
  • [Guideline] National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 07-4051. 2007.
  • Braman SS. The global burden of asthma. Chest. Jul 2006;130(1 Suppl):4S-12S. [Medline].
  • Expert panel-3. NHLBI NIH; AUG 2007. 440. [Full Text].
  • Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. Nov 23 2006;355(21):2226-35. [Medline].
  • Marcus P. Incorporating anti-IgE (omalizumab) therapy into pulmonary medicine practice: practice management implications. Chest. Feb 2006;129(2):466-74. [Medline].
  • Scirica CV, Celedon JC. Genetics of asthma: potential implications for reducing asthma disparities. Chest. Nov 2007;132(5 Suppl):770S-781S. [Medline].
  • [Best Evidence] Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM,. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. Jan 2006;129(1):15-26. [Medline].
  • Rabe KF, Pizzichini E, Stallberg B, Romero S, Balanzat AM, Atienza T. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest. Feb 2006;129(2):246-56. [Medline].
  • [Best Evidence] Pavord ID, Jeffery PK, Qiu Y, Zhu J, Parker D, Carlsheimer A, et al. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. J Allergy Clin Immunol. May 2009;123(5):1083-9, 1089.e1-7. [Medline].
  • Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. May 1996;153(5):1481-8. [Medline].
  • Currie GP, Lee DK, Srivastava P. Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma?. Chest. Oct 2005;128(4):2954-62. [Medline].
  • [Best Evidence] Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. Jan 24 2007;CD001563. [Medline].
  • Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003;CD001186.
  • Bruggenjurgen B, Reinhold T, Brehler R, et al. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma. Ann Allergy Asthma Immunol. Sep 2008;101(3):316-24. [Medline].
  • ClinicalTrials.gov. A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma. ClinicalTrials.gov. Available at http://www.clinicaltrials.gov/ct2/show/NCT00252135. Accessed February 26, 2010.
  • Cox G, Thomson NC, Rubin AS, et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med. Mar 29 2007;356(13):1327-37. [Medline].
  • Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest. Jun 2004;125(6):2046-52. [Medline].
  • Hallstrand TS, Bates PW, Schoene RB. Aerobic conditioning in mild asthma decreases the hyperpnea of exercise and improves exercise and ventilatory capacity. Chest. Nov 2000;118(5):1460-9. [Medline].
  • Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet. Oct 23-29 2004;364(9444):1505-12. [Medline].
  • Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med. Mar 29 2007;356(13):1344-51. [Medline].
  • US Food and Drug Administration. National Transition from Chlorofluorocarbon (CFC) Propelled Albuterol Inhalers to Hydrofluroalkane (HFA) Propelled Albuterol Inhalers. FDA Public Health Advisory. FDA web site. August 28, 2008. Available at: http://www.fda.gov/cder/drug/advisory/albuterol_cfc.htm. Accessed January 13, 2009.
  • Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. Feb 2005;115(2):233-42. [Medline].
  • Sander N, Fusco-Walkert SJ, Harder JM, Chipps BE. Dose counting and the use of pressurized metered-dose inhalers: running on empty. Ann Allergy Asthma Immunol. Jul 2006;97(1):34-8. [Medline].
  • Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet. Dec 22 2007;370(9605):2118-25. [Medline].
  • Woessner KM, Simon RA, Stevenson DD. Monosodium glutamate sensitivity in asthma. J Allergy Clin Immunol. Aug 1999;104(2 Pt 1):305-10. [Medline].
  • Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O’Connor GT, Morgan WJ. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. Sep 20 2008;372(9643):1065-72. [Medline].
  • Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. Nov 2005;26(5):948-68. [Medline].
  • Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. Mar 2008;100(3 Suppl 3):S1-148. [Medline].
  • Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. Jan 2006;129(1 Suppl):80S-94S. [Medline].
  • Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. Apr 9 2009;360(15):1487-99. [Medline].
  • Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. Oct 1990;142(4):832-6. [Medline].
  • The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. Oct 12 2000;343(15):1054-63. [Medline].
  • Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. Nov 13 1997;337(20):1405-11. [Medline].
  • Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. Aug 3 2000;343(5):332-6. [Medline].
  • Levenson M. Long-acting beta-agonists and adverse asthma events meta-analysis. Statistical briefing package for Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee, Drug Safety and Risk Management Advisory Committee and Pediatric Advisory Committee. December 10-11, 2008. Available at: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01-FDA.pdf. Accessed January 13, 2009.
  • US Food and Drug Administration. FDA Announces New Safety Controls for Long-Acting Beta Agonists, Medications Used to Treat Asthma. FDA Web site. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm200931.htm. Accessed March 11, 2010.
  • Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. Oct 1999;14(4):902-7. [Medline].
  • Vollmer WM, Markson LE, O’Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med. Nov 1999;160(5 Pt 1):1647-52. [Medline].
  • Li J, Oppenheimer J, Bernstein IL, et al. Attaining asthma control. A practice parameter. J Allerg Clin Immunol. 2005;115:S3-11.
  • [Best Evidence] Fisher EB, Strunk RC, Highstein GR, et al. A randomized controlled evaluation of the effect of community health workers on hospitalization for asthma: the asthma coach. Arch Pediatr Adolesc Med. Mar 2009;163(3):225-32. [Medline].
  • Oppenheimer J, Aaronson D. Impact of recent black box warnings in the allergy world. Ann Allergy Asthma Immunol. Oct 2007;99(4):364-6. [Medline].
  • Adkinson NF Jr, Eggleston PA, Eney D, et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med. Jan 30 1997;336(5):324-31. [Medline].
  • Alberts WM, do Pico GA. Reactive airways dysfunction syndrome. Chest. Jun 1996;109(6):1618-26. [Medline].
  • American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. Nov 1991;144(5):1202-18. [Medline].
  • Barnes PJ. Is immunotherapy for asthma worthwhile?. N Engl J Med. Feb 22 1996;334(8):531-2. [Medline].
  • Barnes PJ. Is there a role for immunotherapy in the treatment of asthma? No. Am J Respir Crit Care Med. Nov 1996;154(5):1227-8. [Medline].
  • Beasley R, Burgess C, Crane J, Pearce N, Roche W. Pathology of asthma and its clinical implications. J Allergy Clin Immunol. Jul 1993;92(1 Pt 2):148-54. [Medline].
  • Blackhall K, Appleton S, Cates CJ. Ionisers for chronic asthma. Cochrane Database Syst Rev. 2003;CD002986. [Medline].
  • Boulet LP, Chapman KR, Cote J, et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med. Jun 1997;155(6):1835-40. [Medline].
  • Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. Oct 1998;102(4 Pt 1):558-62. [Medline].
  • Bousquet J, Lockey R, Malling HJ, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. Nov 1998;81(5 Pt 1):401-5. [Medline].
  • Britton J, Lewis S. Objective measures and the diagnosis of asthma. We need a simple diagnostic test-but don’t yet have one. BMJ. Jul 25 1998;317(7153):227-8. [Medline].
  • [Best Evidence] Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med. Nov 15 2006;174(10):1077-87. [Medline].
  • Burney P. The changing prevalence of asthma?. Thorax. Oct 2002;57 Suppl 2:II36-II39. [Medline].
  • Busse WW. Mechanisms and advances in allergic diseases. J Allergy Clin Immunol. Jun 2000;105(6 Pt 2):S593-8. [Medline].
  • Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. Feb 1 2001;344(5):350-62. [Medline].
  • Christopher KL, Wood RP 2nd, Eckert RC, Blager FB, Raney RA, Souhrada JF. Vocal-cord dysfunction presenting as asthma. N Engl J Med. Jun 30 1983;308(26):1566-70. [Medline].
  • Corren J, Casale T, Deniz Y, Ashby M. Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. J Allergy Clin Immunol. Jan 2003;111(1):87-90. [Medline].
  • Creticos PS, Reed CE, Norman PS, et al. Ragweed immunotherapy in adult asthma. N Engl J Med. Feb 22 1996;334(8):501-6. [Medline].
  • Cross S, Buck S, Hubbard J. Allergy in general practice. BMJ. May 23 1998;316(7144):1584-7. [Medline].
  • Demoly P, Bousquet J. Anti-IgE therapy for asthma. Am J Respir Crit Care Med. Jun 1997;155(6):1825-7. [Medline].
  • Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. Aug 12 1999;341(7):468-75. [Medline].
  • Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med. Jun 1997;155(6):1828-34. [Medline].
  • Gaga M, Papageorgiou N, Zervas E, Gioulekas D, Konstantopoulos S. Control of asthma under specialist care: is it achieved?. Chest. Jul 2005;128(1):78-84. [Medline].
  • Gardner MO, Doyle NM. Asthma in pregnancy. Obstet Gynecol Clin North Am. Jun 2004;31(2):385-413, vii. [Medline].
  • Georgitis JW. Immunotherapy and Allergen Avoidance for Allergic Airways Disorders. Lesson 3, Vol 12. Northbrook, Ill: American College of Chest Physicians; 1997:[Full Text].
  • Gergen PJ, Mortimer KM, Eggleston PA, et al. Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J Allergy Clin Immunol. Mar 1999;103(3 Pt 1):501-6. [Medline].
  • Hamid Q, Tulic’ MK, Liu MC, Moqbel R. Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol. Jan 2003;111(1 Suppl):S5-S12; discussion S12-7. [Medline].
  • Herxheimer H, Schaefer O. Letter: Asthma in Canadian Eskimos. N Engl J Med. Dec 26 1974;291(26):1419. [Medline].
  • Holgate ST. Science, medicine, and the future. Allergic disorders. BMJ. Jan 22 2000;320(7229):231-4. [Medline].
  • Hughes AT. Anti-IgE antibody may help treat some asthma patients. JAMA. Dec 13 2000;284(22):2859-60. [Medline].
  • Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. Mar 2005;60(3):309-16. [Medline].
  • Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. Oct 1999;14(4):902-7. [Medline].
  • Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. Jan 4 2001;344(1):30-7. [Medline].
  • Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest. Nov 2006;130(5):1541-6. [Medline].
  • Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol. Dec 2004;16(6):702-8. [Medline].
  • Kwon HL, Belanger K, Bracken MB. Effect of pregnancy and stage of pregnancy on asthma severity: a systematic review. Am J Obstet Gynecol. May 2004;190(5):1201-10. [Medline].
  • Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969 to 1991. N Engl J Med. Dec 8 1994;331(23):1542-6. [Medline].
  • Larche M. Regulatory T cells in allergy and asthma. Chest. Sep 2007;132(3):1007-14. [Medline].
  • Legorreta AP, Christian-Herman J, O’Connor RD, Hasan MM, Evans R, Leung KM. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Arch Intern Med. Mar 9 1998;158(5):457-64. [Medline].
  • Lewis SA, Britton JR. Measles infection, measles vaccination and the effect of birth order in the aetiology of hay fever. Clin Exp Allergy. Dec 1998;28(12):1493-500. [Medline].
  • Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. Aug 1999;104(2 Pt 1):301-4. [Medline].
  • Li JT, Pearlman DS, Nicklas RA, et al. Algorithm for the diagnosis and management of asthma: a practice parameter update: Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. Nov 1998;81(5 Pt 1):415-20. [Medline].
  • Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. May 10 1999;159(9):941-55. [Medline].
  • Littner MR, Leung FW, Ballard ED 2nd, Huang B, Samra NK,. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. Sep 2005;128(3):1128-35. [Medline].
  • Livingston E, Thomson NC, Chalmers GW. Impact of smoking on asthma therapy: a critical review of clinical evidence. Drugs. 2005;65(11):1521-36. [Medline].
  • Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma–United States, 1960-1995. MMWR CDC Surveill Summ. Apr 24 1998;47(1):1-27. [Medline].
  • Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. Jan 19 1995;332(3):133-8. [Medline].
  • Matricardi PM, Rosmini F, Ferrigno L, et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ. Apr 5 1997;314(7086):999-1003. [Medline].
  • Milgrom H. Is there a role for treatment of asthma with omalizumab?. Arch Dis Child. Jan 2003;88(1):71-4. [Medline].
  • Milgrom H, Fick RB Jr, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med. Dec 23 1999;341(26):1966-73. [Medline].
  • Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. Feb 2002;109(2):251-6. [Medline].
  • National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma: Expert Panel Report 2. NIH Publication No. 97-4051. Bethesda, Md: 1997:[Full Text].
  • National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics–2002. J Allergy Clin Immunol. Nov 2002;110(5 Suppl):S141-219. [Medline].
  • Nelson HS. Allergen immunotherapy: where is it now?. J Allergy Clin Immunol. Apr 2007;119(4):769-79. [Medline].
  • Nelson HS. The Bela Schick lecture for 1985. The atopic diseases. Ann Allergy. Sep 1985;55(3):441-7. [Medline].
  • Newman-Taylor A. Environmental determinants of asthma. Lancet. Feb 4 1995;345(8945):296-9. [Medline].
  • Norman PS. Is there a role for immunotherapy in the treatment of asthma? Yes. Am J Respir Crit Care Med. Nov 1996;154(5):1225-6. [Medline].
  • Oba Y, Salzman GA. Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma. J Allergy Clin Immunol. Aug 2004;114(2):265-9. [Medline].
  • Osborne ML, Vollmer WM, Pedula KL, Wilkins J, Buist AS, O’Hollaren M. Lack of correlation of symptoms with specialist-assessed long-term asthma severity. Chest. Jan 1999;115(1):85-91. [Medline].
  • Pearce N, Douwes J, Beasley R. Is allergen exposure the major primary cause of asthma?. Thorax. May 2000;55(5):424-31. [Medline].
  • Peat JK, Li J. Reversing the trend: reducing the prevalence of asthma. J Allergy Clin Immunol. Jan 1999;103(1 Pt 1):1-10. [Medline].
  • Pollart SM, Smith TF, Morris EC, Gelber LE, Platts-Mills TA, Chapman MD. Environmental exposure to cockroach allergens: analysis with monoclonal antibody-based enzyme immunoassays. J Allergy Clin Immunol. Feb 1991;87(2):505-10. [Medline].
  • Rambasek TE, Lang DM, Kavuru MS. Omalizumab: where does it fit into current asthma management?. Cleve Clin J Med. Mar 2004;71(3):251-61. [Medline].
  • Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev. 2003;CD002884. [Medline].
  • Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment: an evidence-based evaluation. Chest. Jun 2002;121(6):1977-87. [Medline].
  • Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med. Oct 10 1991;325(15):1067-71. [Medline].
  • Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet. Jun 29 1996;347(9018):1792-6. [Medline].
  • Sheikh A, Alves B, Dhami S. Pneumococcal vaccine for asthma. Cochrane Database Syst Rev. 2002;CD002165. [Medline].
  • Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science. Jan 3 1997;275(5296):77-9. [Medline].
  • Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA. Jul 21 2004;292(3):367-76. [Medline].
  • Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. Sep 1997;156(3 Pt 1):787-93. [Medline].
  • Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med. Aug 23 1990;323(8):502-7. [Medline].
  • Sullivan TJ, Selner JC, Patterson R, et al. Expert care and immunotherapy for asthma. A review of published studies with emphasis on patient outcome and cost. American College of Allergy, Asthma, and Immunotherapy Monograph. Nov 1996;1-25.
  • Theodoropoulos DS, Lockey RF. Allergen immunotherapy: guidelines, update, and recommendations of the World Health Organization. Allergy Asthma Proc. May-Jun 2000;21(3):159-66. [Medline].
  • Tilles SA. Differential diagnosis of adult asthma. Med Clin North Am. Jan 2006;90(1):61-76. [Medline].
  • Turkeltaub PC. FDA Medical Bulletin. 1994;24:7.
  • von Hertzen L, Haahtela T. Signs of reversing trends in prevalence of asthma. Allergy. 2005/03;60(3):283-92.
  • Weinberger M, Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics. Oct 2007;120(4):855-64. [Medline].
  • Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. Jan 2001;107(1):3-8. [Medline].
  • Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2003;CD002893. [Medline].
  • McFadden ER Jr. Exercise-induced airway obstruction. Clin Chest Med. Dec 1995;16(4):671-82. [Medline].
  • Randolph C. Exercise-induced asthma: update on pathophysiology, clinical diagnosis, and treatment. Curr Probl Pediatr. Feb 1997;27(2):53-77. [Medline].
  • [Guideline] National Heart, Lung, and Blood Institute. Global Strategy for Asthma Management and Prevention. NIH Publication. 2008;[Full Text].
  • [Guideline] Williams SG, Schmidt DK, Redd SC, Storms W. Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep. Mar 28 2003;52:1-8. [Medline].
  • [Guideline] National Heart, Lung, and Blood Institute. Education for a partnership in asthma care. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program (NAEPP). Aug 2007;[Full Text].
  • [Guideline] National Heart, Lung, and Blood Institute. Managing asthma long term-special situations. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program (NAEPP). Aug 2007;[Full Text].
  • [Guideline] National Heart, Lung, and Blood Institute. Managing exacerbations of asthma. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program (NAEPP). Aug 2007;[Full Text].
  • [Guideline] National Heart, Lung, and Blood Institute. Measures of asthma assessment and monitoring. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program (NAEPP). Aug 2007;[Full Text].
  • [Guideline] National Heart, Lung, and Blood Institute. Medications. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program (NAEPP). Aug 2007;[Full Text].
  • [Guideline] National Heart, Lung, and Blood Institute. Managing asthma long term in children 0-4 years of age and 5-11 years of age. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program (NAEPP). Aug 2007;[Full Text].
  • [Guideline] National Heart, Lung, and Blood Institute. Managing asthma long term in youths >=12 years of age and adults. Expert panel report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program (NAEPP). Aug 2007;[Full Text].
  • Busse WW, Calhoun WF, Sedgwick JD. Mechanism of airway inflammation in asthma. Am Rev Respir Dis. Jun 1993;147(6 Pt 2):S20-4. [Medline].
  • Henderson WR Jr. Role of leukotrienes in asthma. Ann Allergy. Mar 1994;72(3):272-8. [Medline].
  • Horwitz RJ, Busse WW. Inflammation and asthma. Clin Chest Med. Dec 1995;16(4):583-602. [Medline].
  • Sears MR. Consequences of long-term inflammation. The natural history of asthma. Clin Chest Med. Jun 2000;21(2):315-29. [Medline].
  • Centers for Disease Control and Prevention. Asthma–United States, 1982-1992. MMWR Morb Mortal Wkly Rep. Jan 6 1995;43(51-52):952-5. [Medline].
  • Sly RM. Changing asthma mortality. Ann Allergy. Sep 1994;73(3):259-68. [Medline].
  • Burrows B, Barbee RA, Cline MG, Knudson RJ, Lebowitz MD. Characteristics of asthma among elderly adults in a sample of the general population. Chest. Oct 1991;100(4):935-42. [Medline].
  • Martin AJ, Landau LI, Phelan PD. Lung function in young adults who had asthma in childhood. Am Rev Respir Dis. Oct 1980;122(4):609-16. [Medline].
  • Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis. Mar 1990;141(3):640-7. [Medline].
  • Bacci E, Cianchetti S, Bartoli M, et al. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest. Mar 2006;129(3):565-72. [Medline].
  • Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. Nov 30 2002;360(9347):1715-21. [Medline].
  • [Best Evidence] Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. Mar 5 2009;360(10):985-93. [Medline].
  • Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests. Asthma outcome. Am J Respir Crit Care Med. Feb 1994;149(2 Pt 2):S9-18; discussion S19-20. [Medline].
  • Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. Jan 2000;161(1):309-29. [Medline].
  • Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. May 26 2005;352(21):2163-73. [Medline].
  • [Guideline] Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/european Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. Jul 1 2009;180(1):59-99. [Medline].
  • National Heart, Lung, and Blood Institute. NAEPP Working Group Report: Considerations for Diagnosing and Managing Asthma in the Elderly. NIH Publication No. 96-3662. National Institutes of Health; 1996. [Full Text].
  • [Best Evidence] Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. Jan 15 2010;181(2):116-24. [Medline].
  • Kingston HG, Hirshman CA. Perioperative management of the patient with asthma. Anesth Analg. Sep 1984;63(9):844-55. [Medline].
  • Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med. Apr 1995;151(4):969-74. [Medline].
  • Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med. Nov 22 1999;159(21):2582-8. [Medline].
  • Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. Mar 30 1995;332(13):868-75. [Medline].
  • Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. Mar 1992;145(3):669-74. [Medline].
  • McFadden ER Jr, Hejal RB. The pathobiology of acute asthma. Clin Chest Med. Jun 2000;21(2):213-24, vii. [Medline].
  • Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med. Jul 1992;10(4):301-10. [Medline].
  • Rowe BH, Edmonds ML, Spooner CH, Diner B, Camargo CA Jr. Corticosteroid therapy for acute asthma. Respir Med. Apr 2004;98(4):275-84. [Medline].
  • Nayak A. A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin Pharmacother. Mar 2004;5(3):679-86. [Medline].
  • Nelson HS. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma. J Allergy Clin Immunol. Feb 2001;107(2):398-416. [Medline].
  • [Best Evidence] Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev. Apr 15 2009;CD006924. [Medline].
  • Bailey WC, Richards JM Jr, Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. Aug 1990;150(8):1664-8. [Medline].
  • Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med. Feb 1995;151(2 Pt 1):353-9. [Medline].
  • Kotses H, Bernstein IL, Bernstein DI, et al. A self-management program for adult asthma. Part I: Development and evaluation. J Allergy Clin Immunol. Feb 1995;95(2):529-40. [Medline].
  • Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. Jan 2004;113(1):59-65. [Medline].
  • [Best Evidence] Coffman JM, Cabana MD, Yelin EH. Do school-based asthma education programs improve self-management and health outcomes?. Pediatrics. Aug 2009;124(2):729-42. [Medline].
  • Hamilos DL. Gastroesophageal reflux and sinusitis in asthma. Clin Chest Med. Dec 1995;16(4):683-97. [Medline].
  • Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. Jul 2000;162(1):34-9. [Medline].
  • Harding SM, Sontag SJ. Asthma and gastroesophageal reflux. Am J Gastroenterol. Aug 2000;95(8 Suppl):S23-32. [Medline].
  • Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest. Nov 1999;116(5):1257-64. [Medline].
  • Morris MJ, Deal LE, Bean DR, Grbach VX, Morgan JA. Vocal cord dysfunction in patients with exertional dyspnea. Chest. Dec 1999;116(6):1676-82. [Medline].
  • Chan-Yeung M. 2003 Christie Memorial lecture. Occupational asthma–the past 50 years. Can Respir J. Jan-Feb 2004;11(1):21-6. [Medline].
  • Chan-Yeung M. Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians. Chest. Oct 1995;108(4):1084-117. [Medline].
  • National Heart, Lung, and Blood Institute. Executive Summary: Management of Asthma During Pregnancy. NIH Publication No. 92-3279a. National Institutes of Health; 1992.
  • [Guideline] Dombrowski MP, Schatz M. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol. Feb 2008;111(2 Pt 1):457-64. [Medline].
  • [Best Evidence] Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. Jan 15 2010;181(2):116-24. [Medline].
  • Wechsler ME, Lehman E, Lazarus SC, et al. Beta-Adrenergic Receptor Polymorphisms and Response to Salmeterol. Am J Respir Crit Care Med. Mar 1 2006;173(5):519-26. [Medline][Full Text].
  • Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. Feb 15 2010;181(4):315-23. [Medline].
  • CDC. Asthma Prevalence and Control Characteristics by Race/Ethnicity-United States 2002. MMWR Morb Mortal Wkly Rep. Feb 27 2004;53(7):145-8. [Medline][Full Text].
  • Moorman JE, Rudd RA, Johnson CA, et al. National Surveillance for Asthma—United States, 1980-2004. MMWR Surveill Summ. Oct 19 2007;56(8):1-54. [Medline][Full Text].
  • Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and Wheezing in the First Six Years of Life. The Group Health Medical Associates. N Engl J Med. Jan 19 1995;332(3):133-8. [Medline][Full Text].
  • Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A Clinical Index to Define Risk of Asthma in Young Children with Recurrent Wheezing. Am J Respir Crit Care Med. Oct 2000;162(4 Pt 1):1403-6. [Medline][Full Text].
  • [Guideline] Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. Nov 2007;120(5 Suppl):S94-138. [Medline][Full Text].
  • US Food and Drug Administration. FDA Drug Safety Communication: New safety requirements for long-acting inhaled asthma medications called Long-Acting Beta-Agonists (LABA). Human Department of Health and Human services; Feb 18, 2010. 1-4. [Full Text].
  • Lemanske RF, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. March 30, 2010;362:975-85.
  • [Best Evidence] Vuillermin PJ, Robertson CF, Carlin JB, et al. Parent initiated prednisolone for acute asthma in children of school age: randomised controlled crossover trial. BMJ. Mar 1 2010;340:c843. [Medline].
  • [Best Evidence] Cates CJ, Bestall J, Adams N. Holding chambers versus nebulizers for inhaled steroids in chronic asthma. Cochrane Database Syst Rev. Jan 25 2006;(1):CD001491. [Medline][Full Text].
  • [Best Evidence] Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. Jan 2006;129(1):15-26. [Medline].
  • [Best Evidence] Salpeter SR, Wall AJ, Buckley NS. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. Am J Med. Apr 2010;123(4):322-8.e2. [Medline].
  • [Best Evidence] Rachelefsky G. Inhaled corticosteroids and asthma control in children: assessing impairment and risk. Pediatrics. Jan 2009;123(1):353-66. [Medline].
  • [Best Evidence] Coffman JM, Cabana MD, Yelin EH. Do school-based asthma education programs improve self-management and health outcomes?. Pediatrics. Aug 2009;124(2):729-42. [Medline].
  • Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. Oct 12 2000;343(15):1064-9. [Medline][Full Text].
  • Long-Term Effects of Budesonide or Nedocromil in Children with Asthma. The Childhood Asthma Management Program Research Group. N Engl J Med. Oct 12 2000;343(15):1054-63. [Medline][Full Text].
  • Allergy & Asthma Network Mothers of Asthmatics (AANMA). Available at http://www.aanma.org/pharmacy/ph_medicaldevices.htm. Accessed Sep 24 2008.
  • Ginde AA, Espinola JA, Camargo CA Jr. Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993-2005. J Allergy Clin Immunol. Aug 2008;122(2):313-8. [Medline].
  • Epidemiology and Statistics Unit. Trends in asthma morbidity and mortality. January 2009. New York. American Lung Association. Available at http://www.lungusa.org/atf/cf/%7B7a8d42c2-fcca-4604-8ade-7f5d5e762256%7D/ASTHMA%20JAN%202009.PDF.
  • Brenner BE, Holmes TM, Mazal B, Camargo CA Jr. Relation between phase of the menstrual cycle and asthma presentations in the emergency department. Thorax. Oct 2005;60(10):806-9. [Medline].
  • Zimmerman JL, Woodruff PG, Clark S, Camargo CA. Relation between phase of menstrual cycle and emergency department visits for acute asthma. Am J Respir Crit Care Med. Aug 2000;162(2 Pt 1):512-5. [Medline].
  • Workgroup on EMS Management of Asthma Exacerbations. A model protocol for emergency medical services management of asthma exacerbations. Prehosp Emerg Care. Oct-Dec 2006;10(4):418-29. [Medline].
  • [Guideline] National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma – Update on Selected Topics 2002. June 2003. [Full Text].
  • [Guideline] National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma (EPR-3). July 2007. [Full Text].
  • Starobin D, Bolotinsky L, Or J, Fink G, Shtoeger Z. Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack. Isr Med Assoc J. Aug-Sep 2008;10(8-9):568-71. [Medline].
  • Henderson SO, Ahern TL. The utility of serial peak flow measurements in the acute asthmatic being treated in the ED. Am J Emerg Med. Feb 2010;28(2):221-3. [Medline].
  • [Guideline] Rodriguez-Trigo G, Plaza V, Picado C, Sanchis J. [Management according to the Global Initiative for Asthma guidelines of patients with near-fatal asthma reduces morbidity and mortality]. Arch Bronconeumol. Apr 2008;44(4):192-6. [Medline].
  • [Guideline] Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/european Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. Jul 1 2009;180(1):59-99. [Medline].
  • Alvarez GG, Schulzer M, Jung D, Fitzgerald JM. A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J. Jul-Aug 2005;12(5):265-70. [Medline].
  • Appel D, Karpel JP, Sherman M. Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate. J Allergy Clin Immunol. Jul 1989;84(1):90-8. [Medline].
  • Banerji A, Clark S, Afilalo M, et al. Prospective multicenter study of acute asthma in younger versus older adults presenting to the emergency department. J Am Geriatr Soc. Jan 2006;54(1):48-55. [Medline].
  • [Best Evidence] Baren JM, Boudreaux ED, Brenner BE, et al. Randomized controlled trial of emergency department interventions to improve primary care follow-up for patients with acute asthma. Chest. Feb 2006;129(2):257-65. [Medline].
  • Boychuk RB, Yamamoto LG, DeMesa CJ, Kiyabu KM. Correlation of initial emergency department pulse oximetry values in asthma severity classes (steps) with the risk of hospitalization. Am J Emerg Med. Jan 2006;24(1):48-52. [Medline].
  • Brenner BE, Chavda KK, Karakurum MB, et al. Circadian differences among 4,096 emergency department patients with acute asthma. Crit Care Med. Jun 2001;29(6):1124-9. [Medline].
  • Browne GJ, Penna AS, Phung X, Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet. Feb 1 1997;349(9048):301-5. [Medline].
  • Camargo CA, Smithline HA, Malice MP, et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. Feb 15 2003;167(4):528-33. [Medline].
  • Camargo CA, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev. 2003;CD001115. [Medline].
  • Cates CC, Bara A, Crilly JA, Rowe BH. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2003;CD000052. [Medline].
  • Chapman KR, Verbeek PR, White JG, et al. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med. Mar 21 1991;324(12):788-94. [Medline].
  • Cheuk DKL, Chau TCH, Lee SL. A meta-analysis on intravenous magnesium sulfate for treating acute asthma. Arch Dis Child. 2005;90:74-7.
  • Cydulka RK, Emerman CL, Schreiber D, et al. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med. Sep 1999;160(3):887-92. [Medline].
  • Edmonds ML, Camargo CA, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev. 2000;CD002308. [Medline].
  • Edmonds ML, Camargo CA, Saunders LD, et al. Inhaled steroids in acute asthma following emergency department discharge. Cochrane Database Syst Rev. 2000;CD002316. [Medline].
  • Emerman CL, Cydulka RK, Crain EF, et al. Prospective multicenter study of relapse after treatment for acute asthma among children presenting to the emergency department. J Pediatr. Mar 2001;138(3):318-24. [Medline].
  • Emerman CL, Woodruff PG, Cydulka RK, et al. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest. Apr 1999;115(4):919-27. [Medline].
  • Emond SD, Camargo CA, Nowak RM. 1997 National Asthma Education and Prevention Program guidelines: a practical summary for emergency physicians. Ann Emerg Med. May 1998;31(5):579-89. [Medline].
  • Gibbs MA, Camargo CA, Rowe BH, Silverman RA. State of the art: therapeutic controversies in severe acute asthma. Acad Emerg Med. Jul 2000;7(7):800-15. [Medline].
  • Gorelick MH, Stevens MW, Schultz T, Scribano PV. Difficulty in obtaining peak expiratory flow measurements in children with acute asthma. Pediatr Emerg Care. Jan 2004;20(1):22-6. [Medline].
  • Griswold SK, Nordstrom CR, Clark S, et al. Asthma exacerbations in North American adults: who are the “frequent fliers” in the emergency department?. Chest. May 2005;127(5):1579-86. [Medline].
  • Gupta VK, Cheifetz IM. Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr Crit Care Med. Mar 2005;6(2):204-11. [Medline].
  • Hess DR, Acosta FL, Ritz RH, et al. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest. Jan 1999;115(1):184-9. [Medline].
  • Keahey L, Bulloch B, Becker AB, et al. Initial oxygen saturation as a predictor of admission in children presenting to the emergency department with acute asthma. Ann Emerg Med. Sep 2002;40(3):300-7. [Medline].
  • Kelly AM, Kyle E, McAlpine R. Venous pCO(2) and pH can be used to screen for significant hypercarbia in emergency patients with acute respiratory disease. J Emerg Med. Jan 2002;22(1):15-9. [Medline].
  • Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med. May 12 1994;330(19):1329-34. [Medline].
  • Lahn M, Bijur P, Gallagher EJ. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest. Aug 2004;126(2):362-8. [Medline].
  • Lee DL, Hsu CW, Lee H, et al. Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. Acad Emerg Med. Sep 2005;12(9):820-7. [Medline].
  • Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma–United States, 1980-1999. MMWR Surveill Summ. Mar 29 2002;51(1):1-13. [Medline].
  • Martin TG, Elenbaas RM, Pingleton SH. Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acute asthma. Ann Emerg Med. Feb 1982;11(2):70-3. [Medline].
  • McFadden ER, Kiser R, DeGroot WJ. Acute bronchial asthma: Relations between clinical and physiologic manifestations. New Engl J Med. 1973;288:221-225. [Medline].
  • [Best Evidence] Mitra A, Bassler D, Goodman K, et al. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev. 2005;CD001276. [Medline].
  • Nowak RM, Pensler MI, Sarkar DD, et al. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med. Feb 1982;11(2):64-9. [Medline].
  • Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev. 2000;CD002742. [Medline].
  • Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2000;CD000060. [Medline].
  • Pollack CV, Pollack ES, Baren JM, et al. A prospective multicenter study of patient factors associated with hospital admission from the emergency department among children with acute asthma. Arch Pediatr Adolesc Med. Sep 2002;156(9):934-40. [Medline].
  • Radeos MS, Camargo CA. Predicted peak expiratory flow: differences across formulae in the literature. Am J Emerg Med. Nov 2004;22(7):516-21. [Medline].
  • Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulfate treatment for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev. 2000;2:CD001490.
  • Rowe BH, Camargo CA. The use of magnesium sulfate in acute asthma: rapid uptake of evidence in North American emergency departments. J Allergy Clin Immunol. Jan 2006;117(1):53-8. [Medline].
  • Rowe BH, Edmonds ML, Spooner CH, et al. Corticosteroid therapy for acute asthma. Respir Med. Apr 2004;98(4):275-84. [Medline].
  • Scarfone RJ, Fuchs SM, Nager AL, et al. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. Oct 1993;92(4):513-8. [Medline].
  • Singer AJ, Camargo CA, Lampell M, et al. A call for expanding the role of the emergency physician in the care of patients with asthma. Ann Emerg Med. Mar 2005;45(3):295-8. [Medline].
  • Singh AK, Cydulka RK, Stahmer SA, et al. Sex differences among adults presenting to the emergency department with acute asthma. Multicenter Asthma Research Collaboration Investigators. Arch Intern Med. Jun 14 1999;159(11):1237-43. [Medline].
  • [Best Evidence] Teach SJ, Crain EF, Quint DM, et al. Improved asthma outcomes in a high-morbidity pediatric population: results of an emergency department-based randomized clinical trial. Arch Pediatr Adolesc Med. May 2006;160(5):535-41. [Medline].
  • Travers A, Jones AP, Kelly K, et al. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev. 2001;CD002988. [Medline].
  • Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med. Sep 1994;150(3):870-4. [Medline].
  • Weber EJ, Silverman RA, Callaham ML, et al. A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med. Oct 1 2002;113(5):371-8. [Medline
  • Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. May 1999;115(5):1265-70. [Medline].
  • Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ. Mar 23 1996;312(7033):748-52. [Medline].
  • Hornby PJ, Abrahams TP. Pulmonary pharmacology. Clin Obstet Gynecol. Mar 1996;39(1):17-35. [Medline].
  • Mabie WC. Asthma in pregnancy. Clin Obstet Gynecol. Mar 1996;39(1):56-69. [Medline].
  • Mays M, Leiner S. Asthma. A comprehensive review. J Nurse Midwifery. May-Jun 1995;40(3):256-68. [Medline].
  • Nelson-Piercy C, Moore-Gillon J. Asthma in pregnancy. Br J Hosp Med. Feb 7-20 1996;55(3):115-7. [Medline].
  • Rey E, Boulet LP. Asthma in pregnancy. BMJ. Mar 17 2007;334(7593):582-5. [Medline][Full Text].
  • Guideline] Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/european Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. Jul 1 2009;180(1):59-99. [Medline].
  • [Guideline] American College of Obstetricians and Gynecologists (ACOG). Asthma in pregnancy. ACOG practice bulletin; no. 90. Washington (DC): American College of Obstetricians and Gynecologists (ACOG). Feb 2008;[Full Text].
  • Sly RM, O’Donnell R. Stabilization of asthma mortality. Ann Allergy Asthma Immunol. Apr 1997;78(4):347-54. [Medline].
  • Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. Jul 1992;90(1):32-42. [Medline].
  • O’Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet. Aug 26 2006;368(9537):794-803. [Medline].
  • Strunk RC, Weiss ST, Yates KP, Tonascia J, Zeiger RS, Szefler SJ. Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol. Nov 2006;118(5):1040-7. [Medline].
  • Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. Mar 1994;149(3 Pt 1):604-10. [Medline].
  • Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. May 1996;153(5):1481-8. [Medline].
  • Anderson WJ, Watson L. Asthma and the Hygiene Hypothesis. N Engl J Med. May 24 2001;344(21):1643-4. [Medline].
  • Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From Bronchoconstriction to Airways Inflammation and Remodeling. Am J Respir Crit Care Med. May 2000;161(5):1720-45. [Medline][Full Text].
  • [Best Evidence] Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma. N Engl J Med. May 11 2006;354(19):1985-97. [Medline][Full Text].
  • Lemnaske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. Sep 2005;116(3):571-7. [Medline].
  • Zucker, M. Asthma phenotype, genotype may guide future therapies. http://www.pulmonaryreviews.com [serial online]. June 2003;8:Available at http://www.pulmonaryreviews.com/jun03/pr_jun03_phenotype.html.
  • Drazen JM, Yandava CN, Dube L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet. Jun 1999;22(2):168-70. [Medline][Full Text].
  • Thompson EE, Pan L, Ostrovnaya I, Weiss LA, Gern JE, Lemanske RF Jr, et al. Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. J Allergy Clin Immunol. 2007;119(6):1423-9. [Medline].
  • Beuther DA, Martin RJ. Efficacy of a heat exchanger mask in cold exercise-induced asthma. Chest. May 2006;129(5):1188-93. [Medline][Full Text].
  • Knöpfli BH, Luke-Zeitoun M, von Duvillard SP, et al. High incidence of exercise-induced bronchoconstriction in triathletes of the Swiss national team. Br J Sports Med. Aug 2007;41(8):486-91; discussion 491. [Medline].
  • [Best Evidence] Koh MS, Tee A, Lasserson TJ, Irving LB. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database Syst Rev. 2007;3:CD002739. [Medline].
  • Lacroix VJ. Exercise-induced asthma. Phys Sports Med. 1999;27(12):75-92.
  • McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med. May 12 1994;330(19):1362-7. [Medline].
  • National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma – Update on Selected Topics 2002. Bethesda, Md: National Institutes of Health and National Heart, Lung, and Blood Institute; June 2003. NIH publication no. 02-5074. [Full Text].
  • Parsons JP, Kaeding C, Phillips G, ET AL. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. Sep 2007;39(9):1487-92. [Medline].
  • Smith BW, MacKnight JM. Pulmonary. In: Safran MR, McKeag DB, Van Camp SP, eds. Manual of Sports Medicine. Vol 1. Philadelphia, Pa: Lippincott-Raven; 1998:244-9.
  • Storms WW. Asthma associated with exercise. Immunol Allergy Clin North Am. Feb 2005;25(1):31-43. [Medline].
  • Anderson SD. How does exercise cause asthma attacks?. Curr Opin Allergy Clin Immunol. Feb 2006;6(1):37-42. [Medline].
  • Hough DO, Dec KL. Exercise-induced asthma and anaphylaxis. Sports Med. Sep 1994;18(3):162-72. [Medline].
  • Beaudouin E, Renaudin JM, Morisset M, et al. Food-dependent exercise-induced anaphylaxis–update and current data. Allerg Immunol (Paris). Feb 2006;38(2):45-51. [Medline].
  • Stensrud T, Berntsen S, Carlsen KH. Exercise capacity and exercise-induced bronchoconstriction (EIB) in a cold environment. Respir Med. Jul 2007;101(7):1529-36. [Medline].
  • Butcher JD. Exercise-induced asthma in the competitive cold weather athlete. Curr Sports Med Rep. Dec 2006;5(6):284-8. [Medline].
  • Dickinson JW, Whyte GP, McConnell AK, Harries MG. Screening elite winter athletes for exercise induced asthma: a comparison of three challenge methods. Br J Sports Med. Feb 2006;40(2):179-82; discussion 179-82. [Medline].
  • Wilson JJ, Wilson EM. Practical management: vocal cord dysfunction in athletes. Clin J Sport Med. Jul 2006;16(4):357-60. [Medline].
  • Kenn K. [Vocal Cord Dysfunction–what do we really know? A review] [German]. Pneumologie. Jul 2007;61(7):431-9. [Medline].
  • Kaplan TA. Exercise challenge for exercise-induced bronchospasm: confirming presence, evaluating control. Phys Sports Med. 1995;23(8):47-57.
  • Rundell KW, Anderson SD, Spiering BA, Judelson DA. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest. Mar 2004;125(3):909-15. [Medline][Full Text].
  • Storms W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother. Sep 2007;8(13):2173-87. [Medline].
  • Steinshamn S, Sandsund M, Sue-Chu M, Bjermer L. Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Chest. Oct 2004;126(4):1154-60. [Medline][Full Text].

 

Supported  by

 
 
Widodo judarwanto, pediatrician
Children’s Allergy Center Online
Picky Eaters Clinic, Klinik Kesulitan makan Pada Anak

Office : JL Taman Bendungan Asahan 5  Jakarta Pusat  Phone : (021) 70081995 – 5703646email :  judarwanto@gmail.com, www.childrenallergyclinic.wordpress.com/  

Information on this web site is provided for informational purposes only and is not a substitute for professional medical advice. You should not use the information on this web site for diagnosing or treating a medical or health condition. You should carefully read all product packaging. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider.  

  

  

  

Copyright © 2010, Children Allergy Center  Information Education Network. All rights reserved


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: